Sectoral Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$772K Buy
27,500
+350
+1% +$9.32K 0.64% 41
2025
Q4
$676K Sell
27,150
-50,000
-65% -$1.26M 0.54% 48
2025
Q3
$1.97M Hold
77,150
1.21% 32
2025
Q2
$1.87M Buy
77,150
+17,500
+29% +$408K 1.23% 27
2025
Q1
$1.51M Sell
59,650
-18,000
-23% -$471K 1.18% 23
2024
Q4
$2.06M Sell
77,650
-37,000
-32% -$1M 1.38% 20
2024
Q3
$3.32M Sell
114,650
-66,750
-37% -$1.95M 1.96% 9
2024
Q2
$5.08M Sell
181,400
-8,000
-4% -$220K 2.06% 13
2024
Q1
$5.26M Hold
189,400
2.07% 13
2023
Q4
$5.45M Buy
189,400
+32,000
+20% +$967K 2.35% 8
2023
Q3
$5.22M Hold
157,400
1.02% 40
2023
Q2
$5.77M Hold
157,400
0.96% 44
2023
Q1
$6.42M Buy
157,400
+28,000
+22% +$1.21M 1.23% 28
2022
Q4
$6.63M Hold
129,400
1.28% 27
2022
Q3
$5.66M Hold
129,400
1.12% 36
2022
Q2
$6.78M Sell
129,400
-55,500
-30% -$2.83M 1.37% 23
2022
Q1
$9.57M Sell
184,900
-23,500
-11% -$1.22M 1.7% 21
2021
Q4
$12.3M Buy
208,400
+87,500
+72% +$4.34M 1.85% 14
2021
Q3
$5.2M Sell
120,900
-72,500
-37% -$3.21M 0.43% 91
2021
Q2
$7.57M Buy
193,400
+106,000
+121% +$4.12M 0.61% 69
2021
Q1
$3.17M Sell
87,400
-7,500
-8% -$266K 0.24% 87
2020
Q4
$3.49M Sell
94,900
-23,043
-20% -$845K 0.25% 76
2020
Q3
$4.11M Sell
117,943
-114,886
-49% -$4.03M 0.35% 70
2020
Q2
$7.22M Buy
232,829
+195,939
+531% +$6.66M 0.66% 56
2020
Q1
$1.14M Buy
+36,890
New +$1.26M 0.22% 59
2019
Q4
Sell
-193,439
Closed -$6.59M 67
2019
Q3
$6.59M Sell
193,439
-189,086
-49% -$6.88M 1.14% 38
2019
Q2
$15.7M Sell
382,525
-59,234
-13% -$2.35M 1.88% 16
2019
Q1
$17.8M Sell
441,759
-6,535
-1% -$262K 2.14% 11
2018
Q4
$18.6M Sell
448,294
-25,928
-5% -$1.08M 2.52% 11
2018
Q3
$19.8M Sell
474,222
-42,581
-8% -$1.64M 2.11% 14
2018
Q2
$17.8M Sell
516,803
-330,902
-39% -$11.3M 1.99% 17
2018
Q1
$28.5M Sell
847,705
-69,353
-8% -$2.38M 3.13% 8
2017
Q4
$31.5M Sell
917,058
-92,329
-9% -$3.15M 3.94% 5
2017
Q3
$34.2M Sell
1,009,387
-472,505
-32% -$15.2M 4.4% 2
2017
Q2
$47.2M Buy
1,481,892
+270,454
+22% +$8.53M 5.16% 1
2017
Q1
$39.3M Sell
1,211,438
-648,180
-35% -$20.4M 4.59% 3
2016
Q4
$57.3M Buy
1,859,618
+74,451
+4% +$2.27M 6.35% 2
2016
Q3
$57.4M Buy
1,785,167
+528,451
+42% +$17.7M 5.63% 2
2016
Q2
$42M Buy
+1,256,716
New +$40.1M 4.34% 3
2015
Q4
Sell
-1,803,411
Closed -$53.7M 79
2015
Q3
$53.7M Sell
1,803,411
-123,868
-6% -$3.97M 2.46% 13
2015
Q2
$61.3M Buy
1,927,279
+354,651
+23% +$11.6M 2.56% 13
2015
Q1
$51.9M Buy
1,572,628
+297,379
+23% +$9.45M 1.97% 17
2014
Q4
$37.7M Buy
1,275,249
+406,807
+47% +$11.7M 1.69% 21
2014
Q3
$24.4M Buy
+868,442
New +$24.4M 1.03% 28
2013
Q4
Sell
-727,973
Closed -$19.8M 60
2013
Q3
$19.8M Buy
+727,973
New +$19.8M 0.95% 33

Other funds holding PFE

Sectoral Asset Management's PFE Position: Q1 2026 in Review

Sectoral Asset Management increased its Pfizer (PFE) stake by 1.3% in Q1 2026, buying an estimated $9.32K and bringing the position to 27,500 shares worth $772K. The position accounts for 0.64% of the portfolio, ranked #41.

Sectoral Asset Management first reported a position in PFE in Q3 2013 and has held it in 45 quarters since. The position peaked at $61.3M in Q2 2015. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Sectoral Asset Management held 27,500 shares of Pfizer worth $772K as of Q1 2026.
  • Sectoral Asset Management bought 350 Pfizer shares in Q1 2026, an estimated $9.32K.
  • Pfizer made up 0.64% of Sectoral Asset Management's portfolio in Q1 2026, its #41 holding.
  • Sectoral Asset Management first reported a position in Pfizer in Q3 2013 and has held it in 45 quarters since.
  • Sectoral Asset Management's Pfizer position peaked at $61.3M in Q2 2015.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.